dupixent and tirzepatide REFILE-FDA approves expanded label for Regeneron/Sanofi's Zepbound 15 mg/0.5 mL injection

Quantifying heterogeneity in a meta-analysis

Among these agents, semaglutide and liraglutide have consistently shown the strongest cardiovascular benefit, with semaglutide showing additional promise in patients with obesity and HFpEF

Accountability & Lifestyle Coaching Our weight management programs track your progress, provide guidance, and ensure consistent, safe fat loss

Mazdutide is the closest pipeline rival

Macrogol acts locally in the bowel with minimal systemic absorption, making a pharmacological interaction unlikely, though Wegovy's delayed gastric emptying could theoretically affect the transit of any oral medication

17298-37-2 Drug Class Breast Feeding Lactation Milk, Human Complementary Therapies Disclaimer: Information presented in this database is not meant as a substitute for professional judgment